|
|
Science Sparks @ ACTREC
|
4th December 2023 |
Vol. No. 12 ; Issue No. 607 |
|
Publications
|
1. Srinivasan S, Dhamne C, Patkar N, Chatterjee G, Moulik NR, Chichra A, Pallath A, Tembhare P, Shetty D, Subramanian PG, Narula G, Banavali S (2023). KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1. Pediatric Blood Cancer.
2. Wadasadawala T, Datta D, Puchali N, Rane P, Sen S, Mohanty S, Gupta S, Sarin R, Parmar V (2023). Prospective Study of Incidence and Impact of Comorbidities on Breast Cancer Survival from India. Asian Pacific Journal of Cancer Prevention. 24(11):3805-3814.
3. Trivedi V, Noronha V, Sreekanthreddy P, Desai S, Poojary D, Varghese L, Gowda P, Butle A, Mishra R, Bal M, Mittal N, Rane S, Kane S, Basu S, Patil V, Menon N, Singh AK, Chaturvedi P, Chandrani P, Choughule A, Veldore V, Prabhash K, Dutt A. Association of Cutibacterium acnes with human thyroid cancer. Frontiers in Endocrinology . 14: 1152514.
4. Joshi P, Bhattacharya K, Menon MB, Ghosh Laskar S, Joshi A, Patil V, Chaturvedi P (2023). Malignant minor salivary gland neoplasms of larynx: Our experience. Polish Journal of Otolaryngology. 77(5):1-7
5. Mishra N, Dubey S, Kumari A, Khan MA, Kuligina ES, Preobrazhenskaya EV, Romanko AA, Yadav LR, Sarin R, Imyanitov EN, Varma AK (2023). Structural implications of amyloidogenic rare variants Ser282Leu and Gln356Arg identified in h-BRCA1. Proteins: Structure, Function, and Bioinformatics.
6. Gaur T, Ali A, Sharma D, Gupta SK, Gota V, Bagal B, Platzbeckar U, Mishra R, Dutt A, Khattry N, Mills K, Hassan Md., Sandur S, Hasan SK. Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia. Cellular Signalling.
|
|
|
|
Video of the Week
|
|
Stratification of HCC Towards Precision Medicine |
|
|
|
|
|
|
Do You Know?
In, 1903 S.W. Goldberg and Efim London first used radiation therapy to cure cancer. They made use of radium to treat two patients with basal cell carcinoma of the skin.
|
|
|
Cancer News
|
|
Groundbreaking trial results expand treatment options for some people with bladder cancer.
|
National Cancer Institute, 30/11/2023
|
For the first time in decades, people with advanced bladder cancer have more effective treatment options, according to results of two large clinical trials. One treatment the combination of enfortumab vedotin (Padcev) and the immunotherapy drug pembrolizumab (Keytruda)proved to be particularly powerful…
|
|
Scientists find gene therapy reduces liver cancer in animal model.
|
MedicalXpress, 30/11/2023
|
Researchers have shown that inhibiting a specific protein using gene therapy can shrink hepatocellular carcinoma (HCC) in mice. Silencing the galectin 1 (Gal1) protein, which is often over-expressed in HCC, also improved the anti-cancer immune response and increased the number of killer T cells inside tumors…
|
|
|
|
|
|
|
Enhanced treatment of liver carcinoma with a drug-eluting hydrogel.
|
ScienceDaily, 29/11/2023
|
This drug-eluting hydrogel can provide sustained, pH-dependent drug co-delivery and has capabilities for promoting anti-tumor immune responses. This reduces tumor cell proliferation and growth and offers a more efficient means of enabling tumor cell death...
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|